Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 82Brain Neoplasms 79Glioma 63Neoplasms 16Neuroblastoma 15Meningioma 14Medulloblastoma 13Neurofibromatosis 1 10Ependymoma 10Meningeal Carcinomatosis 9Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 8Neurologic Manifestations 6Diffuse Intrinsic Pontine Glioma 6Astrocytoma 6Spinal Cord Neoplasms 5Recurrence 5Central Nervous System Neoplasms 5Pheochromocytoma 4Paraganglioma 4Oligodendroglioma 4Lung Neoplasms 4Sarcoma 3Rhabdoid Tumor 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neuroma, Acoustic 3Neurofibroma, Plexiform 3Head and Neck Neoplasms 3Ganglioneuroblastoma 3

Interventions

Temozolomide 1Radiotherapy, Intensity-Modulated 1Mycophenolic Acid 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Advanced Glioblastoma × CNS × Clear all
NCT07605364 2026-05-26

Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer

Alliance for Clinical Trials in Oncology

Phase 2/3 Not yet recruiting
422 enrolled
CNS

Advanced Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡